Search results

• Your ingredients partner powering health innovation

  Explore how Croda’s smart science, people and high-performance ingredients are shaping the future of Life Sciences and enabling safer, more sustainable innovation.

• Leadership

  Our Board and Executive Committee provide leadership in delivering for our customers and achieving our strategic priorities.

• Croda Foundation

  Introduction to the Croda Foundation, the independently managed, philanthropic arm of Croda International.

• Sustainability Impact Report 2024

  Find our 2024 Sustainability Impact Report here

• Steve Foots, CEO Sustainability Statement 2024

  One of our core philosophies is to take a leadership position in sustainability and innovation in our chosen markets.

• Materiality assessment

  Our Materiality Assessment performed a comprehensive value chain assessment, and identified areas of transformative action within the business

• Sustainability Report archive

  View our sustainability report archives.

• Croda acquires innovative seed enhancement company Incotec

  Operating in one of the fastest growing segments within the crop care market, Incotec develop and supply a wide range of proprietary and sustainable technologies for both vegetable seeds and field crops.

• Acquisition of Iberchem expands reach into high growth fragrances market

  Acquiring the entire issued share capital of Fragrance Spanish Topco, S.L., trading as Iberchem (“the acquisition”), a leading global fragrances and flavours (“F&F”) company.

• Strengthening Life Sciences with the acquisition of Avanti Polar Lipids

  A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.

• Strategic investment Entekno Materials

  A new Smart Partnership focused on the development of a new particle technology that will deliver superior protection benefits to the sun care and personal care markets.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Vietnam

  Croda’s Vietnam office was founded in 2012 and is located in Ho Chi Minh City.

• Brazil

  Croda do Brasil was established in 1974 and the Campinas manufacturing site in 1977.

• Mexico

  In 1977, a joint venture company was formed in Mexico, Quimica Croda SA.

• Croda Half Year Results fireside chat with Morgan Stanley

  Watch our fireside chat with Morgan Stanley from 29 July 2025.

• PTIC divestment

  View the full webinar from the 22 December 2021 discussing the agreement to divest the majority of our PTIC businesses to Cargill Inc.

• Third quarter trading update

  Update on trading from 01 July to 30 September 2023

• Half year 2024 results

  Group performance in line with expectations reflecting more stable market conditions and operational progress

• UK Government to support expansion of Croda's lipid systems manufacturing facility

  31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.